By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Can Thinking Younger Make You Live Longer?
    April 20, 2011
    Image
    Obesity’s Outlook Unchanged
    June 13, 2011
    When It’s An Emergency Elderly Not Treated As Well in Hospitals
    July 16, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Breakthroughs in Gene Targeting in Mouse Can Help Humans
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Breakthroughs in Gene Targeting in Mouse Can Help Humans
Medical EducationMedical InnovationsPolicy & LawTechnology

Breakthroughs in Gene Targeting in Mouse Can Help Humans

Gene targeting in mouse is a growing field of research that has the potential to revolutionize medical treatments.

Aeden Smith
Last updated: December 4, 2022 9:26 pm
Aeden Smith
Share
8 Min Read
health benefits of gene targeting research
DepositPhotos License - Aleutie
SHARE

Gene therapy can have tremendous benefits for people struggling with serious health problems around the world. The National Institute for Health reports that future gene therapy treatments can help with a number of inherited illnesses, including hemophilia, sickle cell disease and cystic fibrosis.

Contents
Gene Targeting in Mice Can Be Invaluable for Humans Struggling with Genetic IllnessesFundamental and technical issues of traditional gene targetingThe recent advancement in gene targeting techniques1.     Homologous recombination-based gene targeting2.    ES Cell-Based Gene TargetingApplications and advantages for the healthcare sector regarding the two technical advancements.

We have talked about the latest gene therapy research and the benefits they can have for our health. Many of the recent breakthroughs in gene therapy are derived from gene targeting advances in mice.

Gene Targeting in Mice Can Be Invaluable for Humans Struggling with Genetic Illnesses

Gene targeting is a homologous recombination-based alternative strategy technique used to modify endogenous genes, which can be implemented for gene deletion, addition, replacement, and base-pair modification. The gene-targeting technique has developed over the decades. It is incredibly interesting to understand when we move from the discovery of the double helix (Watson and Crick, 1953) to the discovery of restriction endonuclease (Werner Arber, 1968) and recombinant DNA technology (Stanley N. Cohen and Herbert W. Boyer, 1972) and the development of most advanced gene-editing tool CISPR-Cas (Jennifer Doudna, Emmanuelle Charpentier, and co-workers, 2012).

There are a number of compelling reasons to invest in gene targeting research. They can help with tissue engineering and cell therapy, which may cure many health problems.

More Read

Global M-Health
Reverse Innovation: What We Can Learn From Global M-Health
FDA Updates List of Recognized Standards, Confusion Ensues
Defending the Mentally Ill Who Smoke
Ready or Not: ICD-10 Will Go Live as Planned Oct. 1st
Drug Delivery Treatments for Cancer Should be Fast-tracked

However, medical scientists still need to make massive progressive in gene targeting before health experts can apply this research. Fortunately, there are some major advances on the horizon. Many of them are due to research on mice, which may be the key to solving many health problems in humans with genetically inherited diseases.

Figure 1. CRISPR/Cas9 gene editing

Fundamental and technical issues of traditional gene targeting

The fundamental issue with gene targeting is the existence of genetic compensation response. Researchers sometimes find that even though the target gene has been identified and verified to be completely silenced, the organism does not lack a functional gene product, but can be detected with corresponding phenotypes as if the gene was not functional. An explanation for this phenomenon is that the gene must be compensated by “helper” genes, as the analysis suggests. 

Gene targeting is accomplished following the transfer of genes, and the most difficult step is the transfer of genes in stem cells. It can be addressed using a highly specific vector with high efficiency for required size gene release, non-detectable by the immune system, easy purification, and large quantity for large-scale application. Following insertion, there may be inflammation or allergic reactions; it should correct the deficiency, hinder harmful activities, and augment the normal function. Introduction new gene inside a cell and keeping that working is highly specific.

Flanking allele or hitchhiking gene issue: Alterations occur in an allele not because of natural selection but rather due to nearby genes present on the same chromosomes. Such issues develop due to the insertion of a new gene in genetic material.

Genetic variance-related issues: Alterations in the sequence of a gene are genetic variances, due to which malfunctioning of proteins translated from that gene occurs.

The recent advancement in gene targeting techniques

1.     Homologous recombination-based gene targeting

In gene targeting by homologous recombination, the exchange of genetic material between the genome and exogenous deoxyribonucleic acid occurs by cross-over. Homologous sequence acts via cellular enzymatic machinery that guides these exchanges. In the gene of interest, targeted alterations are accomplished through homologous recombination. Such modification mechanisms facilitate the exploration of gene function (functional genomics) and the human genetic diseases model. So this makes gene targeting technology a valuable gizmo for modern genomic studies and related disease treatment. Technology advancement allows direct enzyme repair by inducing target site-specific DNA damage. It is achieved by using transcription like activator effector nucleases, zinc-finger nucleases, triplex-forming oligonucleotides, and CRISPR (clustered regularly interspaced short palindromic repeats). The ribonucleic acid interface (RNAi) helps to ensure the suppression of anti-recombinogenic pathways. Such techniques revolutionized gene targeting efficiency.

Figure 2: Depicting the homologous recombination-based gene targeting. With the assistance of a selection marker (enzymes), the target gene is modified following its alignment with the gene of interest.

2.    ES Cell-Based Gene Targeting

In embryonic stem cells, the endogenous gene locus is altered via homologous recombination, which will help generate mice with targeted mutations. Embryonic stem cells carrying the desired gene mutation are microinjected into blastocyst stage embryos. These microinjected embryos will then be transferred into pseudopregnant surrogate mother mice for further development. These surrogate mice will deliver and nurse the chimeric offspring, which are then bred to establish the knockout mouse line.

Figure 3: Depicting the production of the knockout mouse through gene targeting. A. The specific homologous region of the gene of interest is transferred to the embryonic stem cells through electroporation. The endogenous gene is replaced by the target gene. B. The target embryonic stem cell is transferred into the blastocoel cavities of blastocyst embryos. The embryo is transferred to surrogate mothers for development. The ES cell-derived chimeric mice with variable degrees of chimerism are obtained.

Applications and advantages for the healthcare sector regarding the two technical advancements.

There are a number of ways that the healthcare sector can benefit from this research:

  • For determining the gene function through insertion or deletion mutation
  • Animal model development (via insertion of the human genome in animals) for exploring the relationship between human diseases and genes. (Mainly model is used due to susceptibility of mouse model towards human pathogens)
  • The pathogen gene is inserted for evaluation of such gene in the pathogenicity of a specific pathogen (Mainly viruses)
  • The reporter gene is introduced for in vivo as well as in vitro gene expression analysis.

Cyagen, a well-reputed company, provides genetically engineered mice as well as services for gene editing. The targeting mutations in the specific cell or tissue or whole mouse gnome can help develop the transgenic and knockout mouse. A period of about 1 year is needed for the development of the gene-targeted mouse.

TAGGED:gene targetinggene therapy
Share This Article
Facebook Copy Link Print
Share
By Aeden Smith
Follow:
Aeden Smith-Ahearn is the treatment coordinator for Experience Ibogaine treatment centers in Mexico. After dealing with heroin addiction for over 7 years, Aeden put his last hope into Ibogaine treatment. Now, 5 years later, Aeden has helped thousands of addicts find freedom and sobriety through Ibogaine treatment. He feels overwhelmingly blessed every day to be helping addicts find happiness in life.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

Medical Ethics

It’s All the Doctors’ Fault

September 14, 2011
AddictionAddiction RecoveryTechnology

What To Know About The Role Of Technology In Drug Recovery

November 25, 2019

Global Handwashing Day: Support Global Handwashing

October 13, 2011

ICD 10 Transition Guide

September 21, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?